MetaCap

Monte Rosa Therapeutics Statistics

NASDAQ: GLUEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.64-0.27 (-3.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Monte Rosa Therapeutics by the numbers

Monte Rosa Therapeutics has a market capitalization of $738.3 million based on 85.45M shares outstanding. With trailing EPS of $-1.39, Monte Rosa Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.9% below its 50-day average and 47.5% below its 200-day average.

Average daily trading volume is 1.37M shares, or about $11.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

GLUE valuation vs. peer median

GLUE compared with the median of 8 peer companies
MetricGLUEPeer medianDifference
Market cap$738.29M$747.44M-1%
Avg. volume1.37M776.09K+76%

Peer median across 8 companies: AURA, SLDB, MGTX, ATTO, PRME, BBTX, ODTX, IAM.

Valuation

Market cap
$738.29M
Price / sales (latest FY)
5.97
EPS (TTM)
$-1.39

Price and trading

Previous close
8.91
Open
8.73
Day range
8.48 – 9.04
52-week range
8.48 – 25.77
52-week change
-39.24%
Beta
—
Volume
2.52M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
738.29M
Forward Pe
-4.95
Eps
-1.39
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
25.77
Week52 Low
8.48
Avg Volume
1.37M
Shares Outstanding
85.45M
Ma50
10.78
Ma200
16.46
Earnings Date
Nov 5, 2026
Pct From52w High
-66.47%
Pct From52w Low
1.89%

Related